UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ☐ | Definitive Proxy Statement | |
| ☒ | Definitive Additional Materials | |
| ☐ | Soliciting Material under §240.14a-12 | |
AKEBIA THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. | |||
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
| (1) | Title of each class of securities to which transaction applies:
| |||
| (2) | Aggregate number of securities to which transaction applies:
| |||
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
| (4) | Proposed maximum aggregate value of transaction:
| |||
| (5) | Total fee paid:
| |||
| ☐ | Fee paid previously with preliminary materials. | |||
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
| (1) | Amount Previously Paid:
| |||
| (2) | Form, Schedule or Registration Statement No.:
| |||
| (3) | Filing Party:
| |||
| (4) | Date Filed:
| |||
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting To Be Held on June Your 2, 2021 Vote Counts! AKEBIA THERAPEUTICS, INC.
2021 Annual Meeting
June 2, 2021 10:00 AM EDT Virtual Meeting Site:
www.virtualshareholdermeeting.com/AKBA2021
AKEBIA THERAPEUTICS, INC. 245 FIRST STREET
CAMBRIDGE, MA 02142
D48981-P55376
You invested in AKEBIA THERAPEUTICS, INC. and it’s time to vote!
You have the right to
vote on proposals being presented at the Annual Meeting.
Get informed before you vote
View the Notice, Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 19, 2021. If you would
like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call
1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number
(indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
To view the proxy materials and to vote, visit
www.ProxyVote.com Control #
Vote in Advance of the Meeting Smartphone users
Vote by June 1, 2021
11:59 PM EDT. For shares held Point your camera
here and in a Plan, vote by May 27, 2021 11:59 PM EDT.
vote without entering a Visit www.ProxyVote.com control number
Vote Virtually at the Meeting*
Vote on June 2, 2021 10:00 AM EDT
Visit www.virtualshareholdermeeting.com/AKBA2021
*Please check the meeting materials for any
special requirements for virtual meeting attendance.
V1
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE
BALLOT
This is an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the
important information contained in the proxy materials before voting. Please follow the instructions on the reverse side to vote these important matters.
Voting
Items Board Recommends
1. Election of two Class I Directors
Nominees:
01) Steven C. Gilman, Ph.D. For 02) Cynthia Smith
2. Approval, on an advisory
basis, of the compensation of the company’s named executive officers, as described in the For company’s Proxy Statement.
3. Ratification of the
appointment of Ernst & Young LLP as the company’s independent registered public accounting firm For for the fiscal year ending December 31, 2021.
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.
D48982-P55376